Entyvio (Vedolizumab) Long Term Safety Study

Completed

Conditions studied: Ulcerative Colitis and Crohn's Disease

In brief

The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis (UC) or Crohn's Disease (CD).

Key facts

Study ID
NCT02674308
Run by
Takeda
People needed
5302
Starts
2015-03-24
Expected to finish
2021-07-30
Last updated by the study team
2024-10-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.